{"id":"https://openalex.org/W4242522656","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.3004","title":"A phase I dose-escalation study of oral MK-2206 (allosteric AKT inhibitor) with oral selumetinib (AZD6244; MEK inhibitor) in patients with advanced or metastatic solid tumors.","display_name":"A phase I dose-escalation study of oral MK-2206 (allosteric AKT inhibitor) with oral selumetinib (AZD6244; MEK inhibitor) in patients with advanced or metastatic solid tumors.","publication_year":2011,"publication_date":"2011-05-20","ids":{"openalex":"https://openalex.org/W4242522656","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.3004"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.15_suppl.3004","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.3004","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.3004","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060992997","display_name":"Anthony W. Tolcher","orcid":"https://orcid.org/0000-0002-6322-9721","observed_orcids":["https://orcid.org/0000-0002-6322-9721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. W. Tolcher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080215197","display_name":"Richard D. Baird","orcid":"https://orcid.org/0000-0001-7071-6483","observed_orcids":["https://orcid.org/0000-0001-7071-6483"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. D. Baird","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070570779","display_name":"Amita Patnaik","orcid":"https://orcid.org/0000-0002-4144-2193","observed_orcids":["https://orcid.org/0000-0002-4144-2193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Patnaik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"V. Moreno Garcia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Moreno Garcia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022467575","display_name":"Kyriakos P. Papadopoulos","orcid":"https://orcid.org/0000-0002-0667-2620","observed_orcids":["https://orcid.org/0000-0002-0667-2620"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. P. Papadopoulos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077113399","display_name":"C. R. Garrett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. R. Garrett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072116005","display_name":"David Olmos","orcid":"https://orcid.org/0000-0002-7003-4826","observed_orcids":["https://orcid.org/0000-0002-7003-4826"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Olmos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068858626","display_name":"Krishna Shannon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. A. Shannon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063095096","display_name":"V. Zazulina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Zazulina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013356258","display_name":"E. H. Rubin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. H. Rubin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030659230","display_name":"I. C. Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. C. Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091026280","display_name":"J. Ryan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Ryan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038010720","display_name":"Paul D. Smith","orcid":"https://orcid.org/0009-0005-5418-2545","observed_orcids":["https://orcid.org/0009-0005-5418-2545"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. D. Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042567464","display_name":"A. Taylor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Taylor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052027970","display_name":"Maria Learoyd","orcid":"https://orcid.org/0000-0002-0376-3551","observed_orcids":["https://orcid.org/0000-0002-0376-3551"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Learoyd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045593405","display_name":"Lisa C. Lupinacci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Lupinacci","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046271065","display_name":"L. Yan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Yan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. S. De Bono","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"15_suppl","first_page":"3004","last_page":"3004"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.79830002784729,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.79830002784729,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.17219999432563782,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mk-2206","display_name":"MK-2206","score":0.9879999756813049},{"id":"https://openalex.org/keywords/selumetinib","display_name":"selumetinib","score":0.9279999732971191},{"id":"https://openalex.org/keywords/allosteric-akt-inhibitor","display_name":"allosteric AKT inhibitor","score":0.7910000085830688},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6499999761581421},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.859000027179718},{"id":"https://openalex.org/keywords/raf-mek-erk-pathway","display_name":"Raf/MEK/ERK pathway","score":0.9879999756813049},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.7590000033378601},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.6850000023841858},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9449999928474426},{"id":"https://openalex.org/keywords/acneiform-rash","display_name":"acneiform rash","score":0.9380000233650208},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7350000143051147},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9670000076293945},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7839999794960022}],"concepts":[{"id":"https://openalex.org/C2776087337","wikidata":"https://www.wikidata.org/wiki/Q7448840","display_name":"Selumetinib","level":5,"score":0.8817636966705322},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8372894525527954},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.6557232141494751},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.5903043746948242},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5674986839294434},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5641127824783325},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.45513713359832764},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.4343816339969635},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.4302006661891937},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.40153932571411133},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3608752191066742},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.33406883478164673},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33068370819091797},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3284280598163605},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.14448627829551697},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.09094467759132385},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.15_suppl.3004","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.3004","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.3004","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.7900000214576721,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2336866290","https://openalex.org/W2606350123","https://openalex.org/W2593064308","https://openalex.org/W2600236153","https://openalex.org/W2160147190","https://openalex.org/W1967856042","https://openalex.org/W2034389896","https://openalex.org/W2589824760","https://openalex.org/W2152127926","https://openalex.org/W3000587020"],"abstract_inverted_index":{"3004":[0],"Background:":[1],"The":[2,34],"PI3K-Akt":[3],"and":[4,50,182],"RAF/MEK/ERK":[5],"pathways":[6,17,24],"represent":[7],"two":[8,77],"of":[9,22,36,54,58,76,230,243,255],"the":[10,44,55,74,134,160,252],"most":[11],"frequently":[12],"activated":[13],"growth":[14],"factor":[15],"signaling":[16],"in":[18,107,147,190,222,259,275,282],"human":[19],"cancer.":[20,286],"Inhibition":[21],"both":[23],"could":[25],"yield":[26],"greater":[27],"benefits":[28],"than":[29],"inhibiting":[30],"either":[31,98,113],"pathway":[32],"alone.":[33],"objectives":[35],"this":[37,260],"phase":[38],"I":[39],"study":[40,64],"were":[41,94,188],"to":[42,69,206,218],"examine":[43],"safety,":[45],"pharmacokinetics":[46],"(PK),":[47],"pharmacodynamics":[48],"(PD)":[49],"preliminary":[51],"antitumor":[52],"activity":[53],"novel":[56],"combination":[57,108,276],"MK-2206":[59,97,135,152,164,196,207,231],"with":[60,73,90,96,109,156,168,200,235,251,277,284],"selumetinib.":[61],"This":[62],"investigational":[63],"represents":[65],"a":[66],"new":[67],"approach":[68],"early-stage":[70],"drug":[71,257],"development":[72],"collaboration":[75],"pharmaceutical":[78],"companies":[79],"co-developing":[80],"early":[81],"stage":[82],"targeted":[83],"agent":[84],"combinations":[85],"(NCT01021748).":[86],"Methods:":[87],"Eligible":[88],"patients":[89,125,150,193,283],"advanced":[91,285],"solid":[92],"tumors":[93],"treated":[95,128,194],"every":[99],"other":[100],"day":[101],"(QOD)":[102],"or":[103,117,268],"once":[104,114,233],"weekly":[105,234],"(QW),":[106],"selumetinib":[110,157,169,201,210,236,278],"administered":[111,258],"continuously":[112],"daily":[115,119],"(QD)":[116],"twice":[118],"(BID).":[120],"Results:":[121],"To":[122],"date,":[123],"33":[124],"have":[126],"been":[127],"on":[129],"five":[130],"dose":[131,162,204,229],"levels.":[132],"In":[133],"QOD":[136,155,167],"dosing":[137],"schedule,":[138],"dose-limiting":[139,176,219],"Grade":[140],"3":[141],"macular":[142],"skin":[143],"rash":[144,178,221],"was":[145,163,214,239],"reported":[146],"2/3":[148],"evaluable":[149,192,225],"at":[151,195,264],"45":[153,165,265],"mg":[154,166,171,198,212,266,270,280],"75mg":[158,202,237],"BID;":[159,203],"tolerable":[161],"75":[170,279],"QD.":[172],"For":[173],"QW":[174,199,271],"MK-2206,":[175],"acneiform":[177,220],"(n=1),":[179],"stomatitis":[180],"(n=1)":[181,187],"detached":[183],"retinal":[184],"pigment":[185],"epithelium":[186],"observed":[189],"3/7":[191],"90":[197,269],"reduction":[205],"90mg":[208,232],"QW/":[209],"50":[211],"BID":[213],"not":[215],"tolerated":[216,274],"due":[217],"2/":[223],"4":[224],"patients.":[226],"An":[227],"intermediate":[228],"QD":[238,281],"tolerable.":[240],"Preliminary":[241],"assessment":[242],"PK/PD":[244],"data":[245],"suggest":[246],"no":[247],"apparent":[248],"drug-drug":[249],"interactions":[250],"PK":[253],"profile":[254],"each":[256],"combination.":[261],"Conclusions:":[262],"MK2206":[263],"QOD,":[267],"is":[272],"well":[273]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":9}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-05-12T00:00:00"}